Laura Cámpora
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Acne and Rosacea Treatments and Effects, Cytomegalovirus and herpesvirus research, Poxvirus research and outbreaks, Healthcare and Venom Research
Most-Cited Works
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults(2023)692 cited
- → Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis(2019)248 cited
- → Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation(2019)248 cited
- → Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial(2019)190 cited
- → Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons(2024)142 cited
- → Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial(2019)115 cited
- → Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine(2017)72 cited
- → Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials(2019)62 cited
- → Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older(2018)57 cited